223 related articles for article (PubMed ID: 34811926)
1. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
[TBL] [Abstract][Full Text] [Related]
2. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
[TBL] [Abstract][Full Text] [Related]
3. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists.
Norman C; Webling K; Kyslychenko O; Reid R; Krotulski AJ; Farrell R; Deventer MH; Liu H; Connolly MJ; Guillou C; Vinckier IMJ; Logan BK; NicDaéid N; McKenzie C; Stove CP; Gréen H
Drug Test Anal; 2023 Nov; ():. PubMed ID: 38037247
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples.
Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J
J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137
[TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
[TBL] [Abstract][Full Text] [Related]
7. Quantification of MDMB-4en-PINACA and ADB-BUTINACA in human hair by gas chromatography-tandem mass spectrometry.
Wang Y; Pan Y; Yang H; Liu J; Wurita A; Hasegawa K
Forensic Toxicol; 2022 Jul; 40(2):340-348. PubMed ID: 36454410
[TBL] [Abstract][Full Text] [Related]
8. [Simultaneous determination of five indole/indazole amide-based synthetic cannabinoids in electronic cigarette oil by ultra performance liquid chromatography].
Yang Z; Lyu JX; Wu YD; Jiang LW; Li DM
Se Pu; 2023 Jul; 41(7):602-609. PubMed ID: 37387281
[TBL] [Abstract][Full Text] [Related]
9. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
Krotulski AJ; Cannaert A; Stove C; Logan BK
Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
Erol Ozturk Y; Yeter O
J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
[TBL] [Abstract][Full Text] [Related]
12. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.
Kavanagh P; Pechnikov A; Nikolaev I; Dowling G; Kolosova M; Grigoryev A
J Anal Toxicol; 2022 Jul; 46(6):641-650. PubMed ID: 34341821
[TBL] [Abstract][Full Text] [Related]
13. Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse.
Sia CH; Wang Z; Goh EML; Tan YL; Fong CY; Moy HY; Chan ECY
Clin Chem; 2021 Nov; 67(11):1534-1544. PubMed ID: 34387654
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
[TBL] [Abstract][Full Text] [Related]
15. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
[TBL] [Abstract][Full Text] [Related]
16. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
[TBL] [Abstract][Full Text] [Related]
17. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays.
Grafinger KE; Vandeputte MM; Cannaert A; Ametovski A; Sparkes E; Cairns E; Juchli PO; Haschimi B; Pulver B; Banister SD; Stove CP; Auwärter V
Drug Test Anal; 2021 Jul; 13(7):1412-1429. PubMed ID: 33908179
[TBL] [Abstract][Full Text] [Related]
18. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations.
Norman C; Halter S; Haschimi B; Acreman D; Smith J; Krotulski AJ; Mohr ALA; Logan BK; NicDaéid N; Auwärter V; McKenzie C
Drug Test Anal; 2021 Apr; 13(4):841-852. PubMed ID: 33463894
[TBL] [Abstract][Full Text] [Related]
19. In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs.
Deventer MH; Persson M; Norman C; Liu H; Connolly MJ; Daéid NN; McKenzie C; Gréen H; Stove CP
Drug Test Anal; 2024 Jun; 16(6):616-628. PubMed ID: 37903509
[TBL] [Abstract][Full Text] [Related]
20. Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study.
Zhou F; Wang X; Tan S; Shi Y; Xie B; Xiang P; Cong B; Ma C; Wen D
Addict Biol; 2024 Feb; 29(2):e13372. PubMed ID: 38380735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
